ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the appointment of Jedd Comiskey as Senior VP – Head of Europe. Mr. Comiskey has a successful track record in the planning, organization and execution of product launches. Over the course of his career, he has demonstrated innovative, solutio
Outlook Therapeutics, Inc. announced the appointment of Jedd Comiskey as Senior VP ? Head of Europe. Mr. Comiskey has a successful track record in the planning, organization and execution of product.
A new podcast aims to save lives by encouraging patients who have suffered heart attacks, angioplasty or heart surgery to attend cardiac rehabilitation.
Hit the road with racing royalty as they cycle in memory of Pat Smullen offalyexpress.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from offalyexpress.ie Daily Mail and Mail on Sunday newspapers.